A new survey of the marijuana investment community shows that, despite the current downturn in the market, investors are on track to reach their financial objectives.

On Wednesday (October 30), ManifestSeven issued a report on the future of investing for cannabis plays in the public markets.

Sturges Karban, director and CEO of ManifestSeven, said in the report he wasn’t surprised to see the breadth of support for the industry, but was shocked by how confident investors are right now.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

“Investors are seeing the industry’s first major market correction,” said Karban. “And yet, 71 percent of retail investors in the U.S. and 73 percent in Canada say they expect investment in the cannabis industry to significantly grow over the next 12 months.”

Despite the challenges — from market corrections and valuation realignments for public companies — Karban said investors should see this time period as a window of opportunity.

According to the report, which is based on anecdotal information, the majority of investors in the US and Canada believe in the strategy of holding a diverse portfolio of cannabis companies.

The study was conducted by way of consultations with 660 retail investors in the US and Canada, each with a minimum of US$250,000 of investable assets.

ManifestSeven is a California-based cannabis platform for retail distribution with legal players.

The report indicates that there remains a large section of investors looking to enter into the space.

“I think they don’t feel like they know enough to necessarily judge how good an investment is,” Elaine Carey, managing director and co-head of FTI Consulting’s cannabis practice, said as part of the report.

“We have some fairly serious investors coming to us saying, ‘Can you help us understand if this is a good investment?’ — people who, in other fields, would feel pretty comfortable.”

ManifestSeven’s study shows that investors strongly believe their financial goals are going to be met thanks to cannabis investments.

The report’s data indicates that over 80 percent of investor respondents in the US and Canada who already have invested claim to be “completely on track” to meet their financial goals.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Juan Monteverde founder and managing partner at Monteverde & Associates PC a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City is investigating Harvest Health & Recreation, Inc. (“HRVSF” or the “Company”) ( HRVSF ) relating to its proposed acquisition by Trulieve Cannabis Corp. Under the terms of the agreement, HRVSF shareholders will receive 0.1170 shares of Truelieve per share they own.

The investigation focuses on whether Harvest Health & Recreation, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that the Company will be participating at the BMO Capital Markets 16 th Annual Farm to Market Virtual Conference. Chief Executive Officer, Miguel Martin and Chief Financial Officer, Glen Ibbott will be conducting virtual one-on-one meetings with investors throughout the day on Wednesday, May 19 and Thursday, May 20, 2021 .

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) and Matica subsidiary, West Island Culture Inc. (“West Island”) are pleased to introduce our newest cannabis brand to the market CITOYENTM . CITOYENTMis a more accessible brand of quality cannabis to come out of Montreal’s West Island, The People’s Flower.

All CITOYENTM flower products are craft grown, quality cannabis offerings at lower entry prices and with greater volumes in comparison to our premium OuestTM products. There are currently two product families in the CITOYENTMbrand. CITOYENTMGold Star products are high THC craft products. The CITOYENTM Red Star craft products have a mid to high THC range. Both sets of products still offer the strong bag appeal found with the QuestTM brand stemming from our focus on rich terpene profiles and attractive visual attributes. The CITOYENTM brand strives to provide a greater number consumers with a taste of what a high quality bud in the legal market should be.

Keep reading... Show less

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less